Jeffery A. Sosman

5.8k total citations
8 papers, 495 citations indexed

About

Jeffery A. Sosman is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jeffery A. Sosman has authored 8 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jeffery A. Sosman's work include Retinoids in leukemia and cellular processes (3 papers), Renal cell carcinoma treatment (2 papers) and Cancer-related Molecular Pathways (2 papers). Jeffery A. Sosman is often cited by papers focused on Retinoids in leukemia and cellular processes (3 papers), Renal cell carcinoma treatment (2 papers) and Cancer-related Molecular Pathways (2 papers). Jeffery A. Sosman collaborates with scholars based in United States and France. Jeffery A. Sosman's co-authors include Walter M. Stadler, Nicholas J. Vogelzang, Robert J. Amato, David Liebowitz, Everett E. Vokes, David Taber, Joseph I. Clark, Charles M. Shapiro, Timothy M. Kuzel and Veda Diwadkar‐Navsariwala and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Lipid Research and Cancer Epidemiology Biomarkers & Prevention.

In The Last Decade

Jeffery A. Sosman

8 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffery A. Sosman United States 5 273 194 120 107 97 8 495
Aida S. Hansen Denmark 10 509 1.9× 247 1.3× 61 0.5× 72 0.7× 184 1.9× 21 903
Y C Wong Hong Kong 13 385 1.4× 223 1.1× 62 0.5× 44 0.4× 165 1.7× 14 681
Marilena Crescimanno Italy 13 233 0.9× 126 0.6× 48 0.4× 58 0.5× 106 1.1× 16 483
Amy L. Silvers United States 10 360 1.3× 132 0.7× 30 0.3× 88 0.8× 121 1.2× 10 605
A. Pfeifer Switzerland 9 341 1.2× 230 1.2× 27 0.2× 45 0.4× 166 1.7× 14 661
Young‐Lan Park South Korea 17 382 1.4× 171 0.9× 28 0.2× 59 0.6× 129 1.3× 49 659
Almudena Chaves Perez United States 9 176 0.6× 165 0.9× 38 0.3× 27 0.3× 71 0.7× 13 404
Matthew A. Bill United States 13 353 1.3× 224 1.2× 19 0.2× 223 2.1× 65 0.7× 17 837
Da Eun Jeong South Korea 13 351 1.3× 213 1.1× 33 0.3× 129 1.2× 193 2.0× 31 638
Omar Rahal United States 12 331 1.2× 200 1.0× 25 0.2× 54 0.5× 131 1.4× 20 623

Countries citing papers authored by Jeffery A. Sosman

Since Specialization
Citations

This map shows the geographic impact of Jeffery A. Sosman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffery A. Sosman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffery A. Sosman more than expected).

Fields of papers citing papers by Jeffery A. Sosman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffery A. Sosman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffery A. Sosman. The network helps show where Jeffery A. Sosman may publish in the future.

Co-authorship network of co-authors of Jeffery A. Sosman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffery A. Sosman. A scholar is included among the top collaborators of Jeffery A. Sosman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffery A. Sosman. Jeffery A. Sosman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Fenton, Sarah E., et al.. (2020). Hyperacute Onset of Immune Checkpoint Inhibitor–Related Acute Interstitial Nephritis. Kidney International Reports. 5(11). 2084–2088. 4 indexed citations
2.
Liu, Yan, Oriana E. Hawkins, Yingjun Su, et al.. (2012). Targeting aurora kinases limits tumour growth through DNA damage‐mediated senescence and blockade of NF‐κB impairs this drug‐induced senescence. EMBO Molecular Medicine. 5(1). 149–166. 78 indexed citations
3.
Stover, Daniel G., A. Craig Lockhart, Jordan Berlin, et al.. (2008). Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer. Investigational New Drugs. 26(4). 339–345. 1 indexed citations
4.
Hallmeyer, Sigrun, et al.. (2005). A randomized trial of PSA-peptide based, specific active immunotherapy in HLA-A2+ patients with prostate cancer: Comparison of two different vaccination strategies. Journal of Clinical Oncology. 23(16_suppl). 2519–2519. 4 indexed citations
5.
Gustin, David M., Keith A. Rodvold, Jeffery A. Sosman, et al.. (2004). Single-Dose Pharmacokinetic Study of Lycopene Delivered in a Well-Defined Food-Based Lycopene Delivery System (Tomato Paste-Oil Mixture) in Healthy Adult Male Subjects. Cancer Epidemiology Biomarkers & Prevention. 13(5). 850–860. 60 indexed citations
6.
Diwadkar‐Navsariwala, Veda, Janet A. Novotny, David M. Gustin, et al.. (2003). A physiological pharmacokinetic model describing the disposition of lycopene in healthy men. Journal of Lipid Research. 44(10). 1927–1939. 73 indexed citations
7.
Stadler, Walter M., Nicholas J. Vogelzang, Robert J. Amato, et al.. (2000). Flavopiridol, A Novel Cyclin-Dependent Kinase Inhibitor, in Metastatic Renal Cancer: A University of Chicago Phase II Consortium Study. Journal of Clinical Oncology. 18(2). 371–371. 167 indexed citations
8.
Stadler, Walter M., Timothy M. Kuzel, Charles M. Shapiro, et al.. (1999). Multi-Institutional Study of the Angiogenesis Inhibitor TNP-470 in Metastatic Renal Carcinoma. Journal of Clinical Oncology. 17(8). 2541–2541. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aida S. Hansen Breakdown of academic impact, for papers by Y C Wong Breakdown of academic impact, for papers by Marilena Crescimanno Breakdown of academic impact, for papers by Amy L. Silvers Breakdown of academic impact, for papers by A. Pfeifer Breakdown of academic impact, for papers by Young‐Lan Park Breakdown of academic impact, for papers by Almudena Chaves Perez Breakdown of academic impact, for papers by Matthew A. Bill Breakdown of academic impact, for papers by Da Eun Jeong Breakdown of academic impact, for papers by Omar Rahal
Rankless by CCL
2026